Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression

N/ACompletedNCT00205075

University of Wisconsin, Madison47 enrolled

Overview

The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Hepatic Fibrogenesis Hepatitis C

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Outpatient with HCV who is not receiving or planning treatment but is receiving standard of care monitoring every 3 months and is either abstinent from alcohol or drinking only moderately Exclusion Criteria: * HIV co-infection * Treated within the past 6 months * History (hx) of other liver disease * Alcohol use greater than 30 g/day or history of binge drinking in the last year * Decompensated liver disease

Locations (1)

University of Wisconsin

Madison, Wisconsin, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.